metformin has been researched along with Abnormality, Heart in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin intervention was used to further evaluate potential therapeutic amelioration of cardiac dysfunction in this model." | 1.51 | Metformin intervention prevents cardiac dysfunction in a murine model of adult congenital heart disease. ( Archer, SK; Bais, P; Cagnone, G; Chandran, A; Coleman, D; Costa, MW; Forte, E; Furtado, MB; Heineke, J; Hon, O; Kocalis, H; Pandey, R; Patel, HH; Pearson, JT; Philip, V; Ramialison, M; Rosenthal, NA; Schilling, JM; Wilmanns, JC; Wu, Q, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Beltran, C | 1 |
| Cereijo, R | 1 |
| Quesada-López, T | 1 |
| Malpique, R | 1 |
| López-Bermejo, A | 1 |
| de Zegher, F | 1 |
| Ibáñez, L | 1 |
| Villarroya, F | 1 |
| Wilmanns, JC | 1 |
| Pandey, R | 1 |
| Hon, O | 1 |
| Chandran, A | 1 |
| Schilling, JM | 1 |
| Forte, E | 1 |
| Wu, Q | 1 |
| Cagnone, G | 1 |
| Bais, P | 1 |
| Philip, V | 1 |
| Coleman, D | 1 |
| Kocalis, H | 1 |
| Archer, SK | 1 |
| Pearson, JT | 1 |
| Ramialison, M | 1 |
| Heineke, J | 1 |
| Patel, HH | 1 |
| Rosenthal, NA | 1 |
| Furtado, MB | 1 |
| Costa, MW | 1 |
1 trial available for metformin and Abnormality, Heart
| Article | Year |
|---|---|
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemo | 2020 |
1 other study available for metformin and Abnormality, Heart
| Article | Year |
|---|---|
Metformin intervention prevents cardiac dysfunction in a murine model of adult congenital heart disease.
Topics: Animals; Cardiac Output; Energy Metabolism; Heart Defects, Congenital; Hypoglycemic Agents; Male; Me | 2019 |